Veterinary Vaccines

Product Code GIA00136
Publication Date February 2011
Publisher Global Industry Analysts
Product Type Report
Pages 416
ISBN Number not applicable
Change currency
PDF £2,845.00 €3,426 $4,499 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Veterinary Vaccines

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product segments - Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex, Inc., Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Contents

  • 1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
    • Product Definitions and Scope of Study
    • A. Companion Animal Vaccines
    • B. Livestock Vaccines
    • Porcine Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Ovine Vaccines
    • Equine Vaccines
    • Other Animal Vaccines
  • 2.INDUSTRY OVERVIEW & OUTLOOK
    • Global Animal Health Care Industry - A Brief Review
    • Animal Healthcare Market Grows Amidst Recession
    • Veterinary Vaccines Industry Posts Moderate Growth
    • Poultry Vaccines Industry: A Global Scenario
    • Improved Manufacturing Techniques
    • Improved Analysis
    • Scope of the Report
  • 3.MARKET TRENDS & ISSUES
    • Companion Animal Vaccines: Trailing on a High Growth Track
    • OTC Market: A Potential Threat for Veterinarians
    • Small Animal Practitioners Feel the Pinch of Recession
    • Parasiticides, Systemic Agents To Drive The Market
    • Taxonomy of Vaccines
    • Bird Flu - The Aftermath
    • Vaccination - Critical for Controlling Avian Influenza Virus
  • 4.PRODUCT OVERVIEW
    • Vaccines - An Evolutionary Scan
    • Contribution of Animal Research to Vaccine Production
    • Veterinary Medicines- A Brief Review
    • Preventive Medicines
    • Therapeutic Medicines
    • Others
    • Development of Vaccines
    • Production of Vaccines
    • Veterinary Vaccines - An Essential Component of Animal Health Care
    • What Does A Veterinary Vaccine Do?
    • Classification of Veterinary Vaccines
    • Companion Animals Vaccines
    • Canine Vaccines
    • Feline Vaccines
    • Livestock Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Ovine Vaccines
    • Porcine Vaccines
    • Equine Vaccines
    • Aquaculture Vaccines
    • A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
    • Vaccination and Its Reactions
    • Veterinary Vaccines- Latest Breakthroughs
    • Marker vaccines
    • DNA vaccines
    • Gene-deleted vaccines
    • Viral-vectored vaccines
  • 5.NOTES ON SELECT ANIMAL DISEASES
    • Brucellosis
    • Tuberculosis
    • Johne's disease
    • Spirochete Associated Diseases
    • Respiratory Disease in Goats, Sheep, and Cattle
    • Porcine Respiratory Diseases
    • Mastitis
    • African Swine Fever
    • Avian Influenza
    • East Coast Fever
    • Hemorrhagic Septicemia
    • Foot-And-Mouth Disease
    • Japanese Encephalitis
    • Rift Valley Fever
    • Equine Virus
  • 6.PRODUCT INNOVATIONS/INTRODUCTIONS
    • Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax recombinant Vaccines Product Line
    • Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine
    • Intervet Schering-Plough Animal Health Re-Launches EQUILIS® StrepE for Horses
    • Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX combination package PL
    • Pfizer Animal Health Launches INFORCE™ 3
    • Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia
    • Pfizer Animal Health Introduces Bopriva® for Bull and Beef Market in NZ
    • GALVmed, Inter-African Bureau for Animal Resources Launch ECF Vaccine
    • BIVI launches Five New Variants of Vetera® Vaccines
    • Hipra Announces Launch of Suiseng®
    • Aceto Corporation Receives Approval to Sell Suppliera[euro]™ in the US
    • Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs
    • Intervet Schering-Plough Animal Health Introduces PORCILIS PCV Vaccine
    • Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella Disease
    • Intervet Schering Plough Animal Health Introduces Circovirosis Vaccine
    • Pfizer Animal Health Develops Inovocox® Vaccine
    • Intervet/Schering-Plough Animal Health Launches Bravoxin 10
    • Bioject and Merial Rolls Out Derma-Vac NF
    • Defra to Launch Bovine Tuberculosis Vaccine
    • Intervet International Develops Bluetongue Vaccine
    • Hester Biosciences Unveils Anti-Coryza Vaccine
    • Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8 Vaccine
    • Tecnovax Develops Vaccine for Salmon Virus
    • Tamil Nadu Veterinary and Animal Science University and The Indian Veterinary Research Institute Develop Vaccine
    • Lohmann Animal Health Develops AviPro IBD Xtreme
    • Intervet/Schering-Plough Animal Health Launches EquiRab™
    • Lohmann Animal Health Introduces Larger Doses of AviPro® ViBursa CE
    • Lohmann Animal Health International Rolls Out AviBlue
    • Fort Dodge Animal Health Unveils West Nile-Innovator DNA
    • Univet Agricultural Products Introduces Coglapest
    • Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C
    • Pfizer Animal Health Unveils FluSure® XP Defense System
    • Pfizer Animal Health Launches Improvac®
    • Intervet/Schering-Plough Animal Health Develops Onset™ 5 Intranasal (IN) Vaccine
    • Merial Rolls Out BTVPUR AlSap 8
    • Pfizer Animal Health Introduces FarrowSure® GOLD and FarrowSure® GOLD B
    • Schering-Plough Animal Health Unveils CAVALRY 9
    • Lohmann Animal Health Develops BTO2 REO Vaccine
  • 7.PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER
    • Agroinsuvet Introduces New Vaccines
    • Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry
    • Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine Prototype for Birds
    • Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine
    • USDA Approves Use of PreveNile™ Vaccine for Horses
    • Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine
    • Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia
    • Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs
    • Embrex's Poultry Vaccine Inovocox Gets USDA Approval
    • Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine
    • United States Department of Agriculture Grants Conditional License for Necrotic Enteritis Vaccine
    • Fort Dodge Receives USDA License for Pyramid®10
    • USDA Licenses Use of Fort Dodge's Suvaxyn® PCV2 Vaccine in Pigs
    • USDA Grants Conditional License to Pfizer's New Canine Vaccine
  • 8.RECENT INDUSTRY ACTIVITY
    • Centegen Enters into Licensing Partnership with Merial
    • The Ugandan Government Enters into Partnership with Brentec Vaccines International
    • Pfizer Animal Health Kicks Off Equine Business Unit
    • Pfizer Animal Health Acquires Microtek
    • GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
    • Pfizer Animal Health Inks Global Licensing Deal with Epitopix
    • Indian Immunologicals Intends to Establish a New Facility in Hyderabad
    • Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth in the Netherlands
    • Vivalis Signs Commercial License for EB66® Cell Line Platform
    • Ibio Grants Rights of iBioLaunch platform to Government Funded Project
    • Intervet/Schering-Plough Animal Health Unveils Production Center at Boxmeer
    • Globion India Announced Plans to Develop Eight New Vaccines
    • Veterinary Services Department Intends to Upgrade VRI
    • VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN
    • Vical Enters Into Agreement with GenomIdea for Development of DNA Vaccine
    • Intervet/Schering-Plough Animal Health Unveils the New Freeze-drying and Specialized Central Filling Unit
    • Him Electronics Enters into Partnership with Hester Bioscience to Produce Animal Vaccines
    • Intervet/Schering-Plough Animal Health Receives Approval for Nobivac Lepto4
    • Biolex Enters into Collaboration With Merial for Research and Development
    • Intervet/Schering-Plough Animal Health Receives Full License from USDA for Nobivac® Vaccine
    • Intercell Inks License Agreement with Boehringer
    • Intervet/Schering-Plough Recalls PreveNile West Nile Virus Vaccine in the US
    • Merial Gains Full License of ONCEPT™ from USDA
    • Virbac Acquires Veterinary Assets from Pfizer
    • Harbin Pharmaceutical Group Holding Acquires Animal Vaccine Business From Pfizer
    • Boehringer Ingelheim Acquires Certain Cattle Vaccines from Fort Dodge
    • Virbac Acquires 30% Share in Santa Elena
    • Merck and Sanofi-Aventis to Merge their Animal Health Business
    • Elanco to Take Over Pfizer's Animal Health Products Portfolio
    • Boehringer Ingelhei to Acquire Pfizer's Fort Dodge Animal Health Unit
    • ImmunoVaccine Inks Deal with Pfizer
    • Merck Merges with Schering-Plough
    • Pfizer Acquires Wyeth
    • Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine
    • Epitopix Obtains Approval to Sell Siderophore Receptor and Porin Vaccine
    • Phibro Animal Health Acquires Animal Health Division of Abic
    • Fort Dodge Animal Health and Vivalis Sign Commercial License Deal
    • Hester Biosciences Expands Gujarat Based Facility
    • Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR Vaccine with Bovilis® IBR Marker Live
    • Tangshan Yian Biological Engineering Wins Approval from Ministry of Agriculture of China
    • Lohmann Animal Health International Signs an Agreement with Celldex Therapeutics
    • Intervet/Schering-Plough Animal Health Starts New Manufacturing Facility
    • Laprovet Commences New Facility
    • ImmunoVaccine Technologies and La Jolla Institute for Allergy & Immunology Enter into an Agreement
    • Merial Signs a Toll Distribution and Manufacturing Agreement with Newport Laboratories
    • BOEHRINGER INGELHEIM Animal Health Signs Research License Deal with Vivalis
    • AviTech Selects Merial as a Distributor and Service Provider
    • Bayer Inks Agreement with Juvaris
    • Pfizer Inks Agreement with ImmunoVaccine Technologies
    • BioVet Inaugurates BSL-4 Production Unit in India
    • Vaxine to Take over Protein Sciences
    • Pfizer Inaugurates a New Development Facility for Veterinary Vaccines
    • Merial to Establish Animal Vaccine Manufacturing Plant
    • BNC Bioniche Life Sciences Bags Approval to Sell Econiche Vaccines
    • Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division
    • Pfizer's Animal Health Unit Acquires Schering-Plough's Product License in Europe
    • Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario
    • Harbin Veterinary Research Institute Opens Animal Vaccine Manufacturing Base
    • Bioject Medical Technologies Enters into a Long-Term Supply, Development and License Contract with Merial
    • Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough
    • Biochemiq Enters into Partnership with Labovet
    • Microbix Biosystems Purchases Production Plant
    • Beijing Veterinary Biological Product Factory Starts Operation in New Plant
    • Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine Facility
    • Schering-Plough to Sell Health Products of Animals to Pfizer and Virbac
    • Pfizer Group Establishes a Veterinary Vaccines Development Center
    • Phylaxia to Acquire Gazdasagi Radio and Kozep-europai Gazterminal Zrt
    • Bayer HealthCare AG's Animal Health Unit Enters into Licensing Agreement with Juvaris BioTherapeutics
    • Vivalis Enters into a Commercial License Contract with Virbac
    • ImmunoVaccine Technologies Signs Licensing Agreement with Pfizer Animal Health
    • Kaketsuken and Vivalis Extends Research Collaboration
    • Heska Amends Distribution Contract with Agri Laboratories
    • Prevtec Microbia and Saskatchewan Research Council Receives Approval to Market and Manufacture Coliprotec
    • Imugene and Merial Enter into an Agreement
    • Celldex Therapeutics Merges with AVANT Immunotherapeutics' Subsidiary
    • Ceva Sante Animale Acquires Delvet
    • Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals
    • Environmental Risk Management Authority Approves equine Influenza Vaccine
    • Functional Technologies Commences Operations of Phyterra Bio
    • Summit VetPharm Enters into Distribution Partnership with Webster Veterinary Unit
    • PerOs Receives Establishment and Bacterin License from USDA
    • Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines
    • Boehringer Ingelheim Vetmedica Receives Approval for Express® FP and Express® Vaccines from the USDA
  • 9.CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER
    • Merial Bags Major Australian Contract
    • United States Department of Agriculture Approves Intervet Vaccine
    • Merial Pockets Ancare
    • Heska Revises Distribution Agreement with AgriLabs
    • Animal Health International Acquires Kane Veterinary Supplies
    • Industrial Equity Investments Pockets Arysta LifeScience
    • Henry Schein Acquires W&J Dunlop
    • Tecnovax Establishes New Facility
    • Pingtung Agricultural to Set Up an Exclusive Veterinary Park
    • Ouro Fino To Expand Veterinary Product Suite
    • Alpharma Acquires Yantai Jinhai
    • Pfizer Animal Health Acquires Embrex
    • Schering-Plough Acquires Intervet
    • Schering-Plough Acquires Organon BioSciences
    • Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer
    • Crucell Licenses PER.C6® Technology to Pfizer Animal Health
    • Central Veterinary Research Laboratory to Synthesize New Animal Vaccines
    • Pfizer to Shut Down Omaha Animal Vaccine Center
    • IGI Licenses Novasomes to Novavax
    • Bogor Agricultural Institute Collaborates with Shigeta Animal Pharmaceuticals
    • Suguna Poultry Steps into Livestock Vaccine Production Business
    • European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1
    • AVANT Immunotherapeutics & Pfizer Collaborate to Develop Animal Vaccines
    • Intervet International Acquires FMD Vaccine Production Facility from Bayer Healthcare
    • Canadian Food Inspection Agency Authorizes Bioniche E. Coli O157:H7 Cattle Vaccine for Field Use
    • Hemispherx Biopharma Acquires DOGS Molecule Patent
    • Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala
    • Cryosite and Animal Health Australia Form Partnership
    • Hester Pharmaceuticals Plans Capacity Expansion
    • Biovet to Set up Animal Vaccine Plant in Karnataka
    • Bogor Institute of Agricultureand Shigeta Establish JV for Production of CLOSE 5.1 Vaccine
    • IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune
    • Bioject Medical Technologies Signs Three Agreements WithMerial
    • PetCARE Television Network signs Distribution Agreement with Butler Animal Health Supply
    • Poultry Vaccine to be produced in Vladimir
  • 10.RESEARCH AND DEVELOPMENT IN RECENT PAST
    • Scientists Develop New Vaccine Against Disease Related to PCV2
    • Auburn University and Vaxin Researchers Develop Avian Flu Vaccine
    • UK Researchers Develop In-Shell Vaccine for Chicks
    • Researchers in Vietnam Decode the H5N1 Virus Gene
    • Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus
    • University of Warwick Develops Protecting Virus Method
    • New Treatment Measure Against Ovine Salmonella & Brucellosis
    • ICAR Develops Indigenous Bird Flu Vaccine
    • St. Jude Develops Flu Virus Vaccine through Reverse Genetics
    • Researchers Develop Vaccine for Swine Disease
    • Researchers Develop Experimental Vaccine Against 1918 Influenza Virus
    • Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits
    • CEL-SCI's CEL-1000 Peptide Shows Adjuvant Activity
    • Progress in Vaccine for Canine Cancer
  • 11.FOCUS ON SELECT GLOBAL PLAYERS
    • Bayer HealthCare AG (Germany)
    • Biogenesis-Bago (Argentina)
    • Boehringer Ingelheim GmbH (Germany)
    • Heska Corporation (US)
    • Imugene Limited (Australia)
    • Indian Immunologicals Ltd (India)
    • Lohmann Animal Health (US)
    • Merck & Co., Inc. (US)
    • Intervet/Schering-Plough Animal Health (The Netherlands)
    • Merial Ltd. (US)
    • Pfizer, Inc. (US)
    • Embrex, Inc. (US)
    • Fort Dodge Animal Health (US)
    • Protein Sciences Corporation (US)
    • Virbac Corporation (US)
  • 12.GLOBAL MARKET PERSPECTIVE
  • 13.THE UNITED STATES
    • A. Market Analysis
    • Current & Future Analysis
    • H5N1 Virus: A Conundrum for the US Industry
    • Rabies Cases in the US
    • B. Market Analytics
  • 14.EUROPE
    • Market Analysis
  • 14a.FRANCE
    • Market Analysis
  • 14b.GERMANY
    • Market Analysis
  • 14c.ITALY